Company Filing History:
Years Active: 2003
Title: Innovator in Cancer Therapy: Lars Holger Breimer
Introduction: Lars Holger Breimer, based in Danbury, CT, is an accomplished inventor known for his significant contributions to the field of cancer therapy. With a unique approach to treatment, Breimer holds a patent that reflects his dedication to improving patient outcomes in battling cancer.
Latest Patents: Breimer's notable patent is a "Method for Cancer Therapy." This innovative method involves administering a two-component treatment to patients suffering from cancer over a period of up to 15 days. The first component is a pharmaceutical composition containing an active ingredient derived from a specific compound formula. The second component consists of an injection solution that includes paclitaxel as the active ingredient. The careful combination and administration of these components aim to achieve therapeutic effectiveness during a three to four-week treatment cycle, contingent upon tumor control and patient tolerance.
Career Highlights: Lars Holger Breimer works at Hoffmann-La Roche Inc., a leading pharmaceutical company recognized for its commitment to research and development in healthcare. His innovative contributions have garnered attention and demonstrated his expertise in the field of oncology.
Collaborations: Throughout his career, Breimer has collaborated with distinguished colleagues such as Kapil Dhingra and Urvashi Hooda Dhingra. These partnerships have played a crucial role in advancing research and developing effective cancer treatment methodologies.
Conclusion: Lars Holger Breimer's dedication to cancer therapy through innovation exemplifies the critical role that inventors play in advancing medical science. His patented method shows promise in providing new hope for patients battling cancer, demonstrating the impact and importance of innovative thinking in the fight against this formidable disease.